Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001171843-24-005170
Filing Date
2024-09-13
Accepted
2024-09-12 18:39:21
Documents
5
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A f6ka_091224.htm 6-K/A 5136
2 EXHIBIT 99.1 exh_991.htm EX-99.1 245448
3 EXHIBIT 99.2 exh_992.htm EX-99.2 10393
4 EXHIBIT 99.3 exh_993.htm EX-99.3 10388
5 GRAPHIC logo.jpg GRAPHIC 5293
  Complete submission text file 0001171843-24-005170.txt   279840
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-40858 | Film No.: 241296012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)